# AZD6280 Multiple Ascending Dose Study

> **NCT00681317** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 48 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** AZD6280

## Key facts

- **NCT ID:** NCT00681317
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2010-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00681317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00681317, "AZD6280 Multiple Ascending Dose Study". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00681317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*